EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

Complete genome of mangrove-derived anti-MRSA streptomycete, Streptomyces pluripotens MUSC 135T

Hooi-Leng Ser, Kok-Gan Chan, Wen-Si Tan, Wai-Fong Yin, Bey-Hing Goh, Nurul-Syakima Ab Mutalib, Learn-Han Lee

Progress In Microbes & Molecular Biology · 2018

DOI: 10.36877/pmmb.a0000004 ↗

At a glance

Journal article in Progress In Microbes & Molecular Biology, 2018. Written by Hooi-Leng Ser and 6 co-authors. Cited 2 times so far (Crossref). The full text is freely available (open access, CC BY-NC 4.0).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Microorganisms serve as attractive resources, owing to their ability to synthesize structurally-diverse substanceswith various bioactivities. Within the Bacteria domain, members of the genus Streptomyces have demonstrated remarkableability to produce clinically useful, secondary metabolites such as anticancer, antioxidants, antivirals and antibacterials.Streptomyces pluripotens MUSC 135T was isolated as novel strain from mangrove forest in Malaysia. This strain exhibitedbroad spectrum bacteriocin against several pathogens including methicillin-resistant Staphylococcus aureus (MRSA) strainATCC BAA-44, Salmonella typhi ATCC 19430T and Aeromonas hydrophila ATCC 7966T. Thus, the strain was selected forwhole genome sequencing as an attempt to explore its bioactive potential. Here we report the first complete genome of S.pluripotens MUSC 135T genome which comprise of 7.35 Mbp with G+C content of 69.9 %. A total of 6,404 open readingframes (ORFs) were predicted, along with 18 rRNA and 69 tRNA genes. Using bacteriocin mining tool, BAGEL detectedeights gene clusters associated with bacteriocin production including lanthipeptides and linear azol(in)e-containing peptides(LAPs). Members of Streptomyces have contributed greatly towards improving lives, particularly against deadly infectionsand chronic diseases. The availability of S. pluripotens MUSC 135T genome sequence has opened new window for drugdiscovery, particularly for effective drugs against harmful pathogens such as MRSA and certainly deserves further detailedstudy.

Cite

APA

Ser, H., Chan, K., Tan, W., Yin, W., Goh, B., Mutalib, N. A., & Lee, L. (2018). Complete genome of mangrove-derived anti-MRSA streptomycete, Streptomyces pluripotens MUSC 135T. Progress In Microbes & Molecular Biology. https://doi.org/10.36877/pmmb.a0000004

Vancouver

Ser H, Chan K, Tan W, Yin W, Goh B, Mutalib NA, et al. Complete genome of mangrove-derived anti-MRSA streptomycete, Streptomyces pluripotens MUSC 135T. Progress In Microbes & Molecular Biology. 2018. doi:10.36877/pmmb.a0000004

BibTeX
@article{Ser2018,
  author = {Ser, Hooi-Leng and Chan, Kok-Gan and Tan, Wen-Si and Yin, Wai-Fong and Goh, Bey-Hing and Mutalib, Nurul-Syakima Ab and Lee, Learn-Han},
  title = {Complete genome of mangrove-derived anti-MRSA streptomycete, Streptomyces pluripotens MUSC 135T},
  journal = {Progress In Microbes & Molecular Biology},
  year = {2018},
  doi = {10.36877/pmmb.a0000004}
}
Start for free →